Diagnosis and treatment of @entity1318 XXXX : a ten-year review of the clinical features.

@entity1 @entity1318 @entity384 @entity460 @entity594
BACKGROUND/AIMS: To study the clinical features, the diagnosis and treatment efficacy with @entity384 in @entity1 with @entity1318 in a teaching hospital in Eastern Saudi Arabia. METHODOLOGY: Clinical records of @entity1 with the diagnosis of @entity1318 during the period from 2001 to 2012 were reviewed. Their presentation, radiologic, monometric and endoscopic findings as well as treatment outcome with @entity384 were reviewed. RESULTS Results: Thirty-one new @entity1 were diagnosed with @entity1318 during the study period. The mean age at the diagnosis was 36 years, ranging from 14 to 85 years of age. Male to female ratio was 1.4: 1.7. Five @entity1 while waiting received 20mg of long acting @entity460 channel blockers ( @entity594 ) for four months without any impressive result and asked for @entity384 . @entity384 in one-year follow-up revealed 91% satisfaction and long term follow-up of 5 to 10 years showed 83% satisfaction of @entity1 . During procedure and follow-up, no significant complication was noted. CONCLUSIONSAchalasia effects all ages in both sexes. Graded @entity384 ( @entity384 ) is a safe and effective form of symptomatic treatment of @entity1318 without significant complication in the hands of experts.
